Μεταναστευτικες ροες

Χατζηαναγνωστου Γιωργος

Τα μεταναστευτικα καραβανια οπως αυτο στο Μεξικο προερχομενο απο Βενζουελα δεν υπαρχει περιπτωση να σταματησουν οσο υπαρχουν ασυμμετροι πολεμοι οικονομικής επικυριαρχιας

. Η Bενεζουέλα σαν κυριαρχος παιχτης στην παραγωγη πετρελαιου εχει δεχθη απειρες πιεσεις διαλυσης σαν κρατος . Το φαινομενο ειναι μοντελο προσομειωσης ακριβως οπως και στην Ελλαδα αλλα με διαφορετικο τροπο.

Η κατασταση τα επομενα χρονια ειναι στοχευμενη και επικεντρωνεται σε ολες τις χωρες οπου εχουν ενεργειακα αποθεματα.

What USPTO Statistics Don’t Show

The Real IPR Gauntlet: What USPTO Statistics Don’t Show
By Aaric Eisenstein

87.2% of patents in the study, per the table, were subjected to just 1 or 2 IPR petitions – so gang tackling is no big deal. But make this simple observation: If a patent is killed in its first IPR, it can’t possibly be considered for a second one.


Image Source: Deposit Photos.

‘patent troll’

Is being called a ‘patent troll’ defamatory? NH inventor files suit against banking industry to find out
By Steve Brachmann
For the better part of the nearly 250 years of the existence of the United States of America, the U.S. patent system has been one in which inventors could be reasonably sure that their private property rights covering technological innovation would be respected and enforced. Giants of American innovation such as Thomas Alva Edison, Alexander Graham Bell and others not only successfully commercialized their patented inventions, they also protected their competitive advantage by taking patent infringing parties to court. What happened to that illustrious history?

White House Plan To Reduce Drug Prices... Is To EXTEND Patents?

White House Plan To Reduce Drug Prices... Is To EXTEND Patents?
from the that's-not-how-it-works-at-all dept

While Congress is still doing its thing to try to make the US healthcare system an even bigger laughingstock around the world, the White House is apparently considering an executive order targeting high drug prices. Of course, it handed this power over to Joe Grogan, a (very recent) former lobbyist for a giant pharma company, Gilead, that has been at the center of some controversy over its highly priced drugs. Grogan is apparently leading this effort despite not having an ethics waiver, which means he's supposed to recuse himself from these discussions, rather than lead them. But, you know, that's not happening in the swampy, swampy waters of Washington DC. So just what would Grogan suggest as a way to lower drug prices? How about extending pharmaceutical patents? Yes. Extending.

TC Heartland, Kraft Foods Case Makes Waves in Patent Community

Αrt3050 Πέμπτη 30 Μαρτίου 2017
TC Heartland, Kraft Foods Case Makes Waves in Patent Community
This case threatens patent owners’ ability to seek out favorable courts.
BY AMANDA CICCATELLI

Last week, Whirlpool filed an amicus brief with the U.S. Supreme Court in support of Kraft Foods in TC Heartland, LLC v. Kraft Foods Group Brands, LLC. At the end of last year, the Supreme Court agreed to hear TC Heartland’s appeal, seeking restrictions on where patent lawsuits can be filed. TC Heartland argues that patent suits should only be filed in places where the defendant is incorporated or has an established place of business and has allegedly

What Should an Attorney Charge to File and Prosecute a Patent Application?

Art2869 Πεμπτη 23 Μαρτίου 2017
What Should an Attorney Charge to File and Prosecute a Patent Application?
LikeWhat Should an Attorney Charge to File and Prosecute a Patent Application?
Pat Werschulz
Not surprisingly, one of the first questions clients usually ask me is “how much does it cost to get a patent?” While there are some government fees that apply regardless of which attorney you choose to file and prosecute (i.e. prepare the application and shepherd it through to issuance) your patent, the attorneys fees can vary.

ΕΠΙΣΤΗΜΗ ΕΠΙΧΕΙΡΗΜΑΤΙΚΟΤΗΤΑ ΠΟΛΙΤΙΚΟΙ

Αrt2707 Σάββατο 18 Μαρτίου 2017
Χατζηαναγνώστου Γιώργος

Σε χώρα όπου μέσω μνημονίων έχει εγκλωβιστή σε αδιέξοδο, η ανάπτυξη και κατ επέκταση το ΑΕΠ της χώρας μέσω του τρίπτυχου συνεργασίας Επιστήμης ,Επιχειρηματικότητας και πολιτικών είναι το κλειδί της επιτυχίας.
Η Επιστήμη γιατί με το υπάρχον υψηλά καταρτισμένο Ελληνικό στελεχειακό δυναμικό παράγει υπεραξία σε καινοτόμαπροιόντα ή υπηρεσίες  αλλά και συνεισφέρει θετικά στην παραγώμενη αλυσίδα αξίας.

ΕPO annual report 2016

Αrt2642 Tετάρτη 8 Μαρτίου 2017


 www.fotavgeia.blogspot.com

Debunking the Myth that Patents Create a Monopoly

Αrt2463 Κυριακη 26 Φεβρουαρίου 2017
Debunking the Myth that Patents Create a Monopoly
By Gene Quinn

Many inventors operate under the mistaken belief that getting a patent is like owning both Boardwalk and Park Place in the popular board game Monopoly. Unfortunately, turning an issued patent into cash is much more complicated than simply placing hotels on Boardwalk and Park Place. Of course, those who are against patents

Google’s Patent Counsel Explains Dual Role of Patent Attorney and Operations Expert

Αrt2424 Κυριακή 5 Φεβρουαρίου 2017
Google’s Patent Counsel Explains Dual Role of Patent Attorney and Operations Expert
Sylvia Chen talks about her intriguing position, about facing the “iron triangle” challenge, and about Google’s dedication to metrics and measurement, including their tradition of tabulating annual report cards for their outside counsel law firms.
BY ELISA COOPER

As Patent Counsel/Head of Patent Operations at Google, Sylvia Chen tackles the dual role of patent attorney and operations expert, both practicing patent law and overseeing budgeting, process, and procurement for the patent department.

A Tactic To Enhance The Monetization Potential Of Your Patent Portfolio

Αrt2128 Πέμπτη 5 Ιανουαρίου 2017

Filing Continuations – A Tactic To Enhance The Monetization Potential Of Your Patent Portfolio
By GreyB Posted December 23, 2016
In Patent Commercialization

Patent portfolios are one of the most indispensable assets of an organization. When built strategically, portfolios could serve as a Weapon of choice during litigation – be it offensive or a defensive one. In the current era where every dollar counts, a carefully crafted patent portfolio carries the potential to serve as a money-maker in addition to being the weapon of choice.

Why intellectual property is no longer a purely legal matter...or why it shouldn't be

Αrt2095 Τριτη 27 Δεκεμβριου 2016

Why intellectual property is no longer a purely legal matter...or why it shouldn't be
by Marco Thio

The title may cause some upheaval with my attorney colleagues and lawyer friends, but I am willing to take that risk. Since you decided to give this article a try, I have a feeling that you already know what IP, short for intellectual property, is so I will spare you the pitch on patents, trade marks, designs etc. and why you should have them. Historically, IP was a matter requiring legal professionals as it was and still is used to obtain exclusive rights to keep competitors out, secure (some) exclusivity in the market and/or protect your brand. In case someone infringes these rights, you are entitled to act, supported by the legal IP framework. So far, my title doesn’t seem to hold, does it?

Everything You Need to Know About CRISPR, the New Tool that Edits DNA

Everything You Need to Know About CRISPR, the New Tool that Edits DNA
Sarah ZhangFiled to: GIZ EXPLAINS5/06/15 2:10pm



CRISPR, a new genome editing tool, could transform the field of biology—and a recent study on genetically-engineered human embryos has converted this promise into media hype. But scientists have been tinkering with genomes for decades. Why is CRISPR suddenly such a big deal?

The short answer is that CRISPR allows scientists to edit genomes with unprecedented precision, efficiency, and flexibility. The past few years have seen a flurry of “firsts” with CRISPR, from creating monkeys with targeted mutations to preventing HIV infection in human cells. Earlier this month, Chinese scientists announced they applied the technique to nonviable human embryos, hinting at CRISPR’s potential to cure any genetic disease. And yes, it might even lead to designer babies. (Though, as the results of that study show, it’s still far from ready for the doctor’s office.)

Ελληνικές Πατέντες και το αλληθώρισμα του Κράτους

MarketNews | 

Διαμαρτυρόμαστε σαν Έλληνες για την φυγή των εκπαιδευμένων Νέων σε ξένες χώρες .

Από την άλλη μεριά οι επιχειρήσεις αλλά και από την άλλη το ίδιο το Κράτος μέσα στην απελπισία του προσπαθώντας να δώσει διέξοδο, ελπίδα και όραμα, στους άνεργους επιστήμονες και μη χορηγεί βραβεία...Βραβεία για καινοτόμα προϊόντα και υπηρεσίες με στρεβλότητα, και πρωτοφανή αλληθωρισμό δείχνοντας τον μη ορθό τρόπο και επιβεβαιώνοντας την πλημμελή στρατηγική αλλά και καθοδήγηση των νέων προς όφελος των ολιγοπωλίων ...

Διότι ο κάθε νέος ή και αποκλεισμένος ηλικιωμένος όταν έχει μια καινοτόμο ιδέα πρωτίστως πρέπει να την “πατεντάρει” για να μην γίνει η “κλοπή” της ιδέας για ευτελή ποσά αναλογικά ...

Αλλά ποιός μιλάει ευθέως στην Ελλάδα για το χάος που επικρατεί με τις πατέντες και τα τεκταινόμενα πίσω από τα δικηγορικά γραφεία;

Ποιός αναφέρεται στην ανάγκη να υπάρχει γραφείο θεσμικά εξειδικευμένο με ένα σύνολο εξειδικευμένων συνεργατών σε ένα τόσο πολύπλοκο και πολυδαιδαλώδες υποστηρικτικό πλαίσιο διαδικασιών που απευθύνεται στην πατέντα;

Μήπως έχει έρθει η ώρα στην Ελλάδα να υπάρξει μια “δεξαμενή” πατεντών όπως έχουν παγκοσμίως όλες οι “σοβαρές” χώρες όπου μπορούν να μεταπωλούνται διεθνώς;